Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

764 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MicroRNAs targeting EGFR signalling pathway in colorectal cancer.
Mlcochova J, Faltejskova P, Nemecek R, Svoboda M, Slaby O. Mlcochova J, et al. Among authors: svoboda m. J Cancer Res Clin Oncol. 2013 Oct;139(10):1615-24. doi: 10.1007/s00432-013-1470-9. Epub 2013 Jul 2. J Cancer Res Clin Oncol. 2013. PMID: 23817698 Review.
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, Negrini M, Slaby O. Mlcochova J, et al. Among authors: svoboda m. Oncotarget. 2015 Nov 17;6(36):38695-704. doi: 10.18632/oncotarget.5735. Oncotarget. 2015. PMID: 26497852 Free PMC article.
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.
Kiss I, Mlcochova J, Bortlicek Z, Poprach A, Drabek J, Vychytilova-Faltejskova P, Svoboda M, Buchler T, Batko S, Ryska A, Hajduch M, Slaby O. Kiss I, et al. Among authors: svoboda m. Anticancer Res. 2016 Sep;36(9):4955-9. doi: 10.21873/anticanres.11063. Anticancer Res. 2016. PMID: 27630355 Clinical Trial.
764 results